Women had a higher risk of major adverse cardiac events after a diagnosis of ATTR-CM, according to a recent study.

Increased use of SAMA or SAMA and SABA is associated with increased risk for mortality and cardiovascular events among patients with asthma or COPD.

Short-term exposure to extreme heat and cold is associated with an increased risk for heart failure hospitalizations.

The NAC and modified Mayo staging systems are equally effective in defining clinically meaningful prognostic groups in ATTR-CM, research shows.

Adults hospitalized for infective endocarditis and a concurrent substance use disorder experience lower rates of in-hospital mortality.

At the 2026 ESC Congress, Dr. Gerald Watts reported the results of 2 phase 3 trials evaluating plozasiran, an approved FCS therapy, in sHTG.

Updated AHA and ASA guidelines emphasize interprofessional care and inpatient rehabilitation facilities for poststroke recovery.

A new joint scientific statement provides a framework for assessing cardiovascular risk and fitness for duty among tactical athletes.

Arrhythmia-related mortality in patients with congenital heart disease declined overall between 1999 and 2024 despite a recent upward trend.

A virtual reality toolkit may be a feasible intervention for patients that experience anxiety or claustrophobia during PET or CT imaging.

The AAP Committee on Infectious Diseases provides an updated set of recommendations for RSV vaccination among infants and ...

Vutrisiran was associated with favorable cardiac and amyloid changes on imaging in ATTR-CM, according to a recent study.